These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21537683)

  • 1. Modulation of expression and activity of cytochrome P450s and alteration of praziquantel kinetics during murine schistosomiasis.
    Gotardo MA; Hyssa JT; Carvalho RS; De-Carvalho RR; Gueiros LS; Siqueira CM; Sarpa M; De-Oliveira AC; Paumgartten F
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):212-9. PubMed ID: 21537683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of liver microsomal enzymes during the chronic phase of murine schistosomiasis.
    Conte FP; Fidalgo-Neto AA; Manhães-Rocha DA; Paumgartten FJ; De-Oliveira AC
    Braz J Med Biol Res; 2007 May; 40(5):657-62. PubMed ID: 17464427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of hepatic microsomal enzymes in the early phase of murine schistosomiasis.
    Manhães-Rocha DA; Conte FP; Fidalgo-Neto AA; De-Oliveira AC; Ribeiro-Pinto LF; Paumgartten FJ
    Acta Trop; 2005 Jul; 95(1):58-66. PubMed ID: 15862583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities.
    Botros SS; El-Din SH; El-Lakkany NM; Sabra AN; Ebeid FA
    J Parasitol; 2006 Dec; 92(6):1344-9. PubMed ID: 17304818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.
    El-Feky GS; Mohamed WS; Nasr HE; El-Lakkany NM; Seif El-Din SH; Botros SS
    Antimicrob Agents Chemother; 2015; 59(6):3501-8. PubMed ID: 25845870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and bioavailability of different praziquantel brands.
    Botros S; El-Lakkany N; Seif el-Din SH; Sabra AN; Ibrahim M
    Exp Parasitol; 2011 Feb; 127(2):515-21. PubMed ID: 21044626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model.
    Abla N; Keiser J; Vargas M; Reimers N; Haas H; Spangenberg T
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005942. PubMed ID: 28934207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
    Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
    Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria downmodulates mRNA expression and catalytic activities of CYP1A2, 2E1 and 3A11 in mouse liver.
    Carvalho RS; Friedrich K; De-Oliveira AC; Suarez-Kurtz G; Paumgartten FJ
    Eur J Pharmacol; 2009 Aug; 616(1-3):265-9. PubMed ID: 19501084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
    Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
    J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.
    Frezza TF; de Souza AL; Prado CC; de Oliveira CN; Gremião MP; Giorgio S; Dolder MA; Joazeiro PP; Allegretti SM
    Acta Trop; 2015 Oct; 150():182-9. PubMed ID: 26215128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
    Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
    El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
    Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
    Bajiro M; Dana D; Ayana M; Emana D; Mekonnen Z; Zawdie B; Garbi A; Kure A; Zeynudin A
    Parasit Vectors; 2016 Oct; 9(1):560. PubMed ID: 27772528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of pentoxifylline and/or praziquantel in murine schistosomiasis mansoni.
    El-Lakkany N; Nosseir M
    APMIS; 2007 Mar; 115(3):184-94. PubMed ID: 17367463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of praziquantel on the eggs of Schistosoma mansoni, with a note on the implications for managing central nervous system schistosomiasis.
    Richards F; Sullivan J; Ruiz-Tiben E; Eberhard M; Bishop H
    Ann Trop Med Parasitol; 1989 Oct; 83(5):465-72. PubMed ID: 2515814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.
    Botros SS; Hammam O; Mahmoud M; Bergquist R
    APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C19 and CYP2J2 genotypes predict praziquantel plasma exposure among Ethiopian school-aged children.
    Gebreyesus TD; Makonnen E; Telele NF; Barry A; Mnkugwe RH; Gerba H; Dahl ML; Aklillu E
    Sci Rep; 2024 May; 14(1):11730. PubMed ID: 38778126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
    Sabra AN; Botros SS
    J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of praziquantel administration on hepatic stereology of mice infected with Schistosoma mansoni and fed a low-protein diet.
    Barros LA; Costa-Silva M; Biolchini CL; Neves RH; Machado-Silva JR
    Braz J Med Biol Res; 2009 Sep; 42(9):812-5. PubMed ID: 19738986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.